BioWorld MedTech

April 23, 2012

FDA clears Abbott's iFS laser for cataract surgery

Abbott (Abbott Park, Illinois) reported FDA clearance to use its iFS advanced femtosecond laser to create bow-shaped or curved arcuate incisions in corneal surgery, including cataract surgery. Read More

Report from Israel: Tortuous path seen from research to clinic for personalized medicine

Report from Europe: PIP implant failures significantly higher than previously thought

Washington roundup: FDA reposts warning letter months after initial posting

Agreements/contracts: HearPo reveals plan to offer discounted hearing care services

MDD's Fun Facts

Court report: Zeltiq successful in false claims claims case of its cooling system

Restructuring roundup: MAI in plan to realign 3 strategic business units

Patent watch: CLS receives patent for translation risk management

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 23, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 23, 2026.

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...